<DOC>
	<DOC>NCT02874391</DOC>
	<brief_summary>Use of arteriovenous fistula for IV drug administration is controversial and often prohibited by nephrologists. However, we have been using this method in our department for years now in order to keep the patients 'veins for other fistulas in the future. The aim of this study is to evaluate our practice and maybe provide a justification for a larger multi-center study given the importance of this subject in patients with chronic renal failure.</brief_summary>
	<brief_title>Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<criteria>Age &gt; 18 years, functional AV fistula, new kidney transplant recipient Prothetic AV fistula, Very recent AV fistula of less than 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>